科研之友
微信
新浪微博
Facebook
分享链接
摘要
background: the protein max, salivary component of lutzomyia longipalpis, vector of calazar or systemic leishmaniasis, has been used as vaccine for experimental tegumentar leishmaniasis, which vasodilatory and immunomodulatory functions are described. objectives: our purpose was to detect antibodies antimax in sera samples from patients with atl and to verify the genetic and protein expression of max in l. neivai, phlebotomy vector of atl in the area of study. methods: antibodies antimax were detected by elisa in sera from 42 patients with atl and 63 controls. the extraction of proteins and of dna from l. longipalpis (positive control) and l. neivai was accomplished by the method trizol, following for the detection of proteins by electrophoresis, and genetic expression of max by pcr-rflp (polymerase chain reaction-restriction fragment length polymorphism) with the enzymes hha i and rsa i. results: increased titles of antibodies antimax were observed in atl, compared to controls (p=0,0132). electrophoreses of proteins showed similar fractions for l. longipalpis and l. neivai, and for both a protein fraction with molecular weight similarity to max was observed. the genetic expression of max in l. longipalpis and l. neivai was confirmed by pcr-rflp. conclusions: the description of antibodies antimax in atl patients and controls turned indispensable the research of max in the phlebotomy vector of atl in the area of study. for the first time, it was registered protein and genetic expression of max in l. neivai. the antimax detection in controls confirms the previous exposition to prick of phlebotomies. increased titles of antibodies antimax in atl patients suggest previous and natural exposition to the bite and, consequently, to the protein max, not protecting them of disease and discouraging its employment in vaccination.
